Search by Drug Name or NDC

    NDC 65862-0104-10 Efavirenz 50 mg/1 Details

    Efavirenz 50 mg/1

    Efavirenz is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Aurobindo Pharma Limited. The primary component is EFAVIRENZ.

    Product Information

    NDC 65862-0104
    Product ID 65862-104_a02dd4c8-6159-48b0-a79c-c362f1f4daf9
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Efavirenz
    Proprietary Name Suffix n/a
    Non-Proprietary Name Efavirenz
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE
    Route ORAL
    Active Ingredient Strength 50
    Active Ingredient Units mg/1
    Substance Name EFAVIRENZ
    Labeler Name Aurobindo Pharma Limited
    Pharmaceutical Class Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcri
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA078064
    Listing Certified Through 2025-12-31

    Package

    NDC 65862-0104-10 (65862010410)

    NDC Package Code 65862-104-10
    Billing NDC 65862010410
    Package 3 BLISTER PACK in 1 CARTON (65862-104-10) / 10 CAPSULE in 1 BLISTER PACK
    Marketing Start Date 2017-12-15
    NDC Exclude Flag N
    Pricing Information N/A